Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Luise

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Chemmedchem|May 3, 2014
Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductaseElke Persch, Steve Bryson, Nickolay K Todoroff, et al.
Angewandte Chemie (International Ed. in English)|January 4, 2019
Inhibitor-Induced Dimerization of an Essential Oxidoreductase from African TrypanosomesAnnika Wagner, Thien Anh Le, Martha Brennich, et al.
Journal of Medicinal Chemistry|May 26, 2006
Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targetsLucía Otero, Marisol Vieites, Lucía Boiani, et al.
Journal of Medicinal Chemistry|October 27, 2007
In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivativesWilliams Porcal, Paola Hernández, Mariana Boiani, et al.
International Journal of Molecular Sciences|November 11, 2022
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-<i>N</i>-oxide Derivatives against <i>Trypanosoma cruzi</i> as Trypanothione Reductase InhibitorsAlonzo González-González, Oscar Sánchez-Sánchez, R Luise Krauth-Siegel, et al.
Journal of Medicinal Chemistry|August 2, 2017
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs)Santo Previti, Roberta Ettari, Sandro Cosconati, et al.
Molecules (Basel, Switzerland)|February 4, 2017
Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase InhibitorsKarla Fabiola Chacón-Vargas, Benjamin Nogueda-Torres, Luvia E Sánchez-Torres, et al.
Advances in Microbial Physiology|May 7, 2014
The silicon trypanosome: a test case of iterative model extension in systems biologyFiona Achcar, Abeer Fadda, Jurgen R Haanstra, et al.
European Journal of Medicinal Chemistry|October 15, 2017
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activityElisa Uliassi, Giulia Fiorani, R Luise Krauth-Siegel, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Chemmedchem|May 3, 2014
Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductaseElke Persch, Steve Bryson, Nickolay K Todoroff, et al.
Angewandte Chemie (International Ed. in English)|January 4, 2019
Inhibitor-Induced Dimerization of an Essential Oxidoreductase from African TrypanosomesAnnika Wagner, Thien Anh Le, Martha Brennich, et al.
Journal of Medicinal Chemistry|May 26, 2006
Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targetsLucía Otero, Marisol Vieites, Lucía Boiani, et al.
Journal of Medicinal Chemistry|October 27, 2007
In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivativesWilliams Porcal, Paola Hernández, Mariana Boiani, et al.
International Journal of Molecular Sciences|November 11, 2022
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-<i>N</i>-oxide Derivatives against <i>Trypanosoma cruzi</i> as Trypanothione Reductase InhibitorsAlonzo González-González, Oscar Sánchez-Sánchez, R Luise Krauth-Siegel, et al.
Journal of Medicinal Chemistry|August 2, 2017
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs)Santo Previti, Roberta Ettari, Sandro Cosconati, et al.
Molecules (Basel, Switzerland)|February 4, 2017
Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase InhibitorsKarla Fabiola Chacón-Vargas, Benjamin Nogueda-Torres, Luvia E Sánchez-Torres, et al.
Advances in Microbial Physiology|May 7, 2014
The silicon trypanosome: a test case of iterative model extension in systems biologyFiona Achcar, Abeer Fadda, Jurgen R Haanstra, et al.
European Journal of Medicinal Chemistry|October 15, 2017
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activityElisa Uliassi, Giulia Fiorani, R Luise Krauth-Siegel, et al.
Pageof 10